DURECT (DRRX) Insider Buy: Director Increases Direct Holdings to 2.67M Shares
Rhea-AI Filing Summary
R. Scott Asen, a director of DURECT Corp (DRRX), reported an insider purchase on Form 4. The filing shows a purchase of 5,917 shares of DURECT common stock on 08/22/2025 at a price of $1.9194 per share. After the reported transaction the filing lists 2,672,529 shares beneficially owned by the reporting person in a direct capacity. The form also records 970,000 shares held indirectly (30,000 via The Asen Foundation and 940,000 via Asen & Co.) where the reporting person disclaims beneficial ownership except to the extent of pecuniary interest. The filing is signed by R. Scott Asen on 08/26/2025.
Positive
- Director purchase disclosed: R. Scott Asen reported buying 5,917 shares at $1.9194, demonstrating an insider acquisition.
- Clear disclosure of indirect holdings: The filing explains 30,000 shares via The Asen Foundation and 940,000 via Asen & Co.
Negative
- None.
Insights
TL;DR Insider purchase of 5,917 shares at $1.9194 increases the director's direct stake to 2,672,529 shares; transaction size is modest.
The reported open-market purchase is explicit: 5,917 shares acquired on 08/22/2025 at $1.9194. The filing separates direct and indirect holdings, showing significant indirect positions held via a foundation and an advisory firm where the reporting person has voting or investment authority. For valuation context, the filing provides price and share counts but no information on aggregate cost basis or percentage ownership of outstanding shares. This is a routine Section 16 disclosure with no additional corporate actions reported.
TL;DR Director disclosed a small purchase and clarified indirect holdings through related entities, consistent with Section 16 reporting requirements.
The form clearly documents the reporting person's roles and the nature of indirect ownership: Trustee of The Asen Foundation and President of Asen & Co., with voting/dispositive authority over certain shares. The reporting person explicitly disclaims beneficial ownership of those indirectly held shares except for pecuniary interest. The filing is timely and correctly signed, meeting standard governance transparency expectations; it contains no indications of derivative transactions or plan-based trades.